Abstract
ScinoPharm and Lee's Pharmaceutical jointly develop drug products for the Chinese market. WuXi PharmaTech begins construction of new R&D and cGMP manufacturing campus in Changzhou. NeoStem signs Licensing Agreement with Cellular Biomedicine Group and plans to begin Phase 2 hepatocellular carcinoma trial in China. Abiogen Pharma signed agreement with Lee's Pharma to market Neridronic Acid in mainland China, Taiwan, Hong Kong and Macau. InSightec launches its first centers in China. Shuwen Biotech and DiagnoCure sign exclusive agreement for commercializing colorectal cancer staging test in China. The Jackson Laboratory and Frasergen to begin creation of cancer genomics facility in Hubei Province, China. RuiYi and iHuman Institute form collaboration to identify novel antibodies targeting GPCRs. Enigma Diagnostics and China's ICDC collaborate to develop MDX infectious disease assays for use at point-of-care. Drug to inhibit liver cancer discovered.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
